Search research articles
Contact Us
Filters
Showing results (141-150 of 186) with videos related to
Page
of 19
Sort By:
International Journal of Clinical Oncology
|
January 7, 2016
Meta-analysis supporting noninferiority of oxaliplatin plus S-1 to cisplatin plus S-1 in first-line treatment of advanced gastric cancer (G-SOX study): indirect comparison with S-1 alone
Chikuma Hamada, Yasuhide Yamada, Mizutomo Azuma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2026
Comprehensive Genomic and Transcriptomic Characterization of MTAP Loss Across Advanced Solid Tumors
Kyosuke Seguchi, Takao Fujisawa, Sadakatsu Ikeda, et al.
JNCI Cancer Spectrum
|
April 25, 2025
Associations between early tumor shrinkage/depth of response and survival from the ARCAD database
Hideaki Bando, Yuriko Takeda, Toshihiro Misumi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 9, 2022
Updated Efficacy Outcomes of Anti-PD-1 Antibodies plus Multikinase Inhibitors for Patients with Advanced Gastric Cancer with or without Liver Metastases in Clinical Trials
Hiroki Yukami, Akihito Kawazoe, Yi-Tzu Lin, et al.
Therapeutic Advances in Medical Oncology
|
September 23, 2025
Impact of claudin 18.2 expression on treatment outcomes of first-line immunochemotherapy in patients with HER2-negative, proficient MMR, PD-L1 CPS ⩾1 metastatic gastric/gastroesophageal junction cancer
Fei Zhang, Izuma Nakayama, Naoya Sakamoto, et al.
British Journal of Cancer
|
June 4, 2024
Three-year outcomes of preoperative chemoradiotherapy plus nivolumab in microsatellite stable and microsatellite instability-high locally advanced rectal cancer
Yuichiro Tsukada, Hideaki Bando, Koji Inamori, et al.
Journal for Immunotherapy of Cancer
|
February 9, 2024
Multiomic molecular characterization of the response to combination immunotherapy in MSS/pMMR metastatic colorectal cancer
Shogo Takei, Yosuke Tanaka, Yi-Tzu Lin, et al.
The Journal of Liquid Biopsy
|
March 3, 2025
Validity and utility of blood tumor mutational burden (bTMB) is dependent on circulating tumor DNA (ctDNA) shed: SCRUM-Japan MONSTAR-SCREEN
Saori Mishima, Yoshiaki Nakamura, Hanna Tukachinsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2022
Preoperative Chemoradiotherapy plus Nivolumab before Surgery in Patients with Microsatellite Stable and Microsatellite Instability-High Locally Advanced Rectal Cancer
Hideaki Bando, Yuichiro Tsukada, Koji Inamori, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 20, 2024
Novel ERBB2 Variant Potentially Associated with Resistance against Anti-HER2 Monoclonal Antibody-Based Therapy in ERBB2-Amplified Metastatic Colorectal Cancer
Naoko Iida, Mitsuho Imai, Wataru Okamoto, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 186) with videos related to
Sort By:
Page
of 19
International Journal of Clinical Oncology
|
January 7, 2016
Meta-analysis supporting noninferiority of oxaliplatin plus S-1 to cisplatin plus S-1 in first-line treatment of advanced gastric cancer (G-SOX study): indirect comparison with S-1 alone
Chikuma Hamada, Yasuhide Yamada, Mizutomo Azuma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2026
Comprehensive Genomic and Transcriptomic Characterization of MTAP Loss Across Advanced Solid Tumors
Kyosuke Seguchi, Takao Fujisawa, Sadakatsu Ikeda, et al.
JNCI Cancer Spectrum
|
April 25, 2025
Associations between early tumor shrinkage/depth of response and survival from the ARCAD database
Hideaki Bando, Yuriko Takeda, Toshihiro Misumi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 9, 2022
Updated Efficacy Outcomes of Anti-PD-1 Antibodies plus Multikinase Inhibitors for Patients with Advanced Gastric Cancer with or without Liver Metastases in Clinical Trials
Hiroki Yukami, Akihito Kawazoe, Yi-Tzu Lin, et al.
Therapeutic Advances in Medical Oncology
|
September 23, 2025
Impact of claudin 18.2 expression on treatment outcomes of first-line immunochemotherapy in patients with HER2-negative, proficient MMR, PD-L1 CPS ⩾1 metastatic gastric/gastroesophageal junction cancer
Fei Zhang, Izuma Nakayama, Naoya Sakamoto, et al.
British Journal of Cancer
|
June 4, 2024
Three-year outcomes of preoperative chemoradiotherapy plus nivolumab in microsatellite stable and microsatellite instability-high locally advanced rectal cancer
Yuichiro Tsukada, Hideaki Bando, Koji Inamori, et al.
Journal for Immunotherapy of Cancer
|
February 9, 2024
Multiomic molecular characterization of the response to combination immunotherapy in MSS/pMMR metastatic colorectal cancer
Shogo Takei, Yosuke Tanaka, Yi-Tzu Lin, et al.
The Journal of Liquid Biopsy
|
March 3, 2025
Validity and utility of blood tumor mutational burden (bTMB) is dependent on circulating tumor DNA (ctDNA) shed: SCRUM-Japan MONSTAR-SCREEN
Saori Mishima, Yoshiaki Nakamura, Hanna Tukachinsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2022
Preoperative Chemoradiotherapy plus Nivolumab before Surgery in Patients with Microsatellite Stable and Microsatellite Instability-High Locally Advanced Rectal Cancer
Hideaki Bando, Yuichiro Tsukada, Koji Inamori, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 20, 2024
Novel ERBB2 Variant Potentially Associated with Resistance against Anti-HER2 Monoclonal Antibody-Based Therapy in ERBB2-Amplified Metastatic Colorectal Cancer
Naoko Iida, Mitsuho Imai, Wataru Okamoto, et al.
Page
of 19